Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on August 6, 2025
Extendicare Announces 2025 Second Quarter Results
GlobeNewswire
·
August 6, 2025
MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2025. Second Quarter 2025 Highlights Adjusted EBITDA(1), excluding out-of- …
Endometrial Ablation Devices Market Size, Growth Drivers and Global Forecast 2035 | At a Thriving CAGR of 6.59%
EIN Presswire
·
August 6, 2025
The market scope spans a wide range of end-users, including hospitals, ambulatory surgical centers, and specialized gynecology clinics. US, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Endometrial Ablation Devices Market Positioned for Strong …
Protective Clothing For Life Sciences Market to Surge from USD 12.46B (2024) to USD 23.38B (2034) | CAGR 6.50%
EIN Presswire
·
August 6, 2025
global protective clothing for life sciences market was valued at approximately USD 12.46 billion in 2024 is expected to reach around USD 23.38 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 6, 2025 /EINPresswire.com/ -- 🔍 Executive Summary The …
Dermatology Device Market Projected to Hit USD 57.3 Billion by 2035, at a Exceptional CAGR 5.59%
EIN Presswire
·
August 6, 2025
Treatment devices are expected to dominate the market through the forecast period due to their increasing usage in non-invasive cosmetic procedures. US, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Dermatology Device Market Shows Robust …
Anesthesia Respiratory Device Market Anticipated to Achieve 43,823.80 Million USD by 2032 at 8.30% CAGR
EIN Presswire
·
August 6, 2025
Anesthesia Respiratory Device Market is experiencing significant expansion, driven by advancements in patient care technologies, rising surgical procedures NEW YORK, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- The global Anesthesia …
Occupational Health Market Anticipated to Hit USD 62.5 Billion by 2035, Expanding at 4.19% CAGR
EIN Presswire
·
August 6, 2025
Occupational Health Market Research Report By Service Type (Health Screening, Wellness Programs, Occupational Safety Training, Drug Testing, Telehealth Services NEW YORK,, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Occupational Health …
WHX Dubai and WHX Labs Dubai to combine in 2026 to form the world’s largest healthcare event
EIN Presswire
·
August 6, 2025
More than 270,000 professionals from 180 countries and over 4,800 exhibitors will come together in Dubai for one week to shape the industry DUBAI, UNITED ARAB EMIRATES, August 6, 2025 /EINPresswire.com/ -- Informa has announced the launch of the world's …
Cardiovascular Prosthetic Device Market Expected to Surpass USD 123.10 Billion by 2034 with 4.73% CAGR
EIN Presswire
·
August 6, 2025
Cardiovascular Prosthetic Device Market Size, Growth Research Report By Device Type (Heart Valves, Vascular Grafts, Stents, Pacemakers and Defibrillators) NEW YORK,, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Cardiovascular Prosthetic …
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 6, 2025
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
August 6, 2025
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 …
STERIS Announces Chief Financial Officer Transition
GlobeNewswire
·
August 6, 2025
Long-time CFO Michael J. Tokich to be succeeded by Karen L. Burton, Chief Accounting Officer DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that Michael J. Tokich, Senior Vice …
Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
GlobeNewswire
·
August 6, 2025
Safety Review Committee endorses escalation to 160 mg TUS dosing Cohorts with 120 mg, 80 mg, 40 mg TUS dosing completed with no dose-limiting toxicities Excellent safety and complete remissions (CRs) in some of the most difficult-to-treat AML populations …
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
August 6, 2025
Oral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option agreement for novel antibody and advancement of proprietary oral small molecules Strengthened discovery …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
August 6, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and …
STERIS Announces Financial Results for Fiscal 2026 First Quarter
GlobeNewswire
·
August 6, 2025
Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.79; adjusted EPS increased to $2.34 Fiscal 2026 revenue and free cash flow outlook updated DUBLIN, …
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 6, 2025
Enrollment Complete in Cohorts 1 and 2 of MyPEAK™-1 Phase 1b/2 Trial of TN-201 for MYBPC3-associated HCM; Positive DSMB Safety Review Enables Enrollment of Expansion Cohorts Cohort 1 of RIDGE™-1 Phase 1b Trial of TN-401 Enrolled and First PKP2-associated …
Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 6, 2025
Announces positive data for rosnilimab, a pathogenic T cell depleter, through Week 38 from Phase 2b rheumatoid arthritis trial Enrollment completed for rosnilimab Phase 2 ulcerative colitis trial; Top-line data through Week 12 on track for Q4 2025 Ongoing …
DLH Reports Fiscal 2025 Third Quarter Results
GlobeNewswire
·
August 6, 2025
ATLANTA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …
Keros to Exclusively Prioritize the Clinical Advancement of KER-065
GlobeNewswire
·
August 6, 2025
Company Discontinuing Development of Cibotercept (KER-012) Announces Board and Leadership Changes Designed to Support Streamlined Operational Structure and Strategic Realignment LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. …
Certara Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 6, 2025
RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025. Second Quarter Highlights: Revenue was $104.6 …